Literature DB >> 5835501

The treatment of coronary occlusive disease by endarterectomy.

R B Dilley, J A Cannon, A A Kattus, R N MacAlpin, W P Longmire.   

Abstract

Entities:  

Mesh：

Year:  1965        PMID： 5835501

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  8 in total

1.  CORONARY ENDARTERECTOMY: AN ANALYSIS OF ITS ROLE IN AORTOCORONARY BYPASS.

Authors:  Victor Parsonnet; Lawrence Gilbert; I Gielchinsky; E K Bhaktan; T Atherlay
Journal:  Cardiovasc Dis       Date:  1976

2.  [Intravital coronarography from the surgical viewpoint].

Authors:  A Düx
Journal:  Langenbecks Arch Chir       Date:  1969

3.  Combining direct coronary artery surgery with internal mammary artery implants.

Authors:  G L Hammond; I McMillan
Journal:  Thorax       Date:  1970-05       Impact factor: 9.139

4.  The distal coronary bypass.

Authors:  G C Morris; J F Howell; E S Crawford; G J Reul; D W Chapman; H L Beazley; W L Winters; P K Peterson
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

5.  Retrograde coronary sinus perfusion: a method of myocardial protection in the dog during left coronary artery occlusion.

Authors:  G L Hammond; A L Davies; W G Austen
Journal:  Ann Surg       Date:  1967-07       Impact factor: 12.969

6.  Surgery of angina pectoris.

Authors: 
Journal:  Br Med J       Date:  1967-01-21

7.  Early results of coronary artery bypass grafting with coronary endarterectomy for severe coronary artery disease.

Authors:  Jan D Schmitto; Philipp Kolat; Philipp Ortmann; Aron F Popov; Kasim O Coskun; Martin Friedrich; Samuel Sossalla; Karl Toischer; Suyog A Mokashi; Theodor Tirilomis; Mersa M Baryalei; Friedrich A Schoendube
Journal:  J Cardiothorac Surg       Date:  2009-09-22       Impact factor: 1.637

8.  Measurement of regional myocardial perfusion in man with 133 xenon and a scintillation camera.

Authors:  P J Cannon; R B Dell; E M Dwyer
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.